Doctor profile · Federal record
Dr. SCOTT TAGAWA, MD
Hematology & Oncology Physician (CMS: MEDICAL ONCOLOGY) · NEW YORK, NY
- NPI 1245258045
- Accepts Medicare
- MIPS 93.4 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
525 E 68TH ST, STARR 341, WCMC DIVISION OF HEMATOLOGY & ONCOLOGY
NEW YORK, NY 100654870
(212) 746-6717
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- November 10, 2011
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #70818
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1245258045. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,001
Distinct HCPCS
5
Medicare allowed
$147,441
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 673 | 185 | $162 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 230 | 116 | $111 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 40 | 15 | $133 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 32 | 31 | $207 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 26 | 21 | $35 |
In context: peer comparison
Among 103 peers in this city , average services per provider: 411. This provider delivers 2.4× the peer median.Open Payments
Industry payments received
All-time total
$85,084
Transactions
78
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $19,703.94 | |
| GE HEALTHCARE | 7 | $15,865.00 | |
| Janssen Biotech, Inc. | 3 | $10,625.00 | |
| PFIZER INC. | 13 | $8,561.48 | |
| Novartis Pharmaceuticals Corporation | 5 | $7,792.10 | |
| LANTHEUS MEDICAL IMAGING, INC. | 7 | $5,768.31 | |
| Janssen Research & Development, LLC | 3 | $3,531.89 | |
| Telix Pharmaceuticals | 9 | $2,832.81 | |
| Daiichi Sankyo Inc. | 3 | $2,362.33 | |
| Janssen Scientific Affairs, LLC | 1 | $2,225.99 | |
| Gilead Sciences, Inc. | 8 | $2,210.76 | |
| Tolmar, Inc. | 1 | $1,800.00 | |
| Boston Scientific Corporation | 1 | $1,250.00 | |
| AstraZeneca Pharmaceuticals LP | 4 | $313.71 | |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $198.77 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
62
Patients
0
Total drug cost
$34,272
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 14 | 0 | $100 |
| Tamsulosin Hcl | Generic | 13 | 0 | $183 |
| Dexamethasone | Generic | 12 | 0 | $203 |
| Orgovyx (Relugolix) | Brand | 12 | 0 | $33,658 |
| Gabapentin | Generic | 11 | 0 | $128 |